AC Immune SA (ACIU)
2.38
-0.04
(-1.65%)
USD |
NASDAQ |
Apr 18, 16:00
2.40
+0.02
(+0.84%)
Pre-Market: 20:00
AC Immune Market Cap: 235.38M for April 18, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 235.38M |
| April 17, 2024 | 239.34M |
| April 16, 2024 | 242.30M |
| April 15, 2024 | 249.23M |
| April 12, 2024 | 270.98M |
| April 11, 2024 | 269.99M |
| April 10, 2024 | 276.92M |
| April 09, 2024 | 276.92M |
| April 08, 2024 | 276.92M |
| April 05, 2024 | 271.97M |
| April 04, 2024 | 271.97M |
| April 03, 2024 | 276.92M |
| April 02, 2024 | 267.03M |
| April 01, 2024 | 269.99M |
| March 28, 2024 | 292.74M |
| March 27, 2024 | 299.66M |
| March 26, 2024 | 280.87M |
| March 25, 2024 | 286.81M |
| March 22, 2024 | 303.62M |
| March 21, 2024 | 311.53M |
| March 20, 2024 | 321.92M |
| March 19, 2024 | 332.30M |
| March 18, 2024 | 346.15M |
| March 15, 2024 | 346.15M |
| March 14, 2024 | 329.33M |
| Date | Value |
|---|---|
| March 13, 2024 | 367.03M |
| March 12, 2024 | 347.19M |
| March 11, 2024 | 339.26M |
| March 08, 2024 | 374.97M |
| March 07, 2024 | 384.89M |
| March 06, 2024 | 384.89M |
| March 05, 2024 | 391.83M |
| March 04, 2024 | 361.08M |
| March 01, 2024 | 381.91M |
| February 29, 2024 | 359.10M |
| February 28, 2024 | 387.86M |
| February 27, 2024 | 375.96M |
| February 26, 2024 | 373.98M |
| February 23, 2024 | 341.24M |
| February 22, 2024 | 325.37M |
| February 21, 2024 | 331.32M |
| February 20, 2024 | 330.33M |
| February 16, 2024 | 303.55M |
| February 15, 2024 | 298.59M |
| February 14, 2024 | 281.72M |
| February 13, 2024 | 280.73M |
| February 12, 2024 | 287.67M |
| February 09, 2024 | 268.83M |
| February 08, 2024 | 280.73M |
| February 07, 2024 | 263.87M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
143.47M
Minimum
Dec 22 2022
710.69M
Maximum
Jan 15 2020
373.92M
Average
358.87M
Median
Market Cap Benchmarks
| Roche Holding AG | 191.66B |
| CRISPR Therapeutics AG | 4.765B |
| Addex Therapeutics Ltd | 20.99M |
| NLS Pharmaceutics Ltd | 5.749M |
| Molecular Partners AG | 122.88M |
Market Cap Related Metrics
| Price to Book Value | 1.231 |
| Price | 2.38 |
| Earnings Yield | -29.81% |